• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚胺-2,3 双加氧酶:肿瘤微环境的命运改变者。

Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.

机构信息

Department of Surgery, School of Veterinary Medicine and Animal Sciences, University of Sao Paulo, Sao Paulo, Brazil.

Department of Pathology, School of Veterinary Medicine and Animal Sciences, University of Sao Paulo, Sao Paulo, Brazil.

出版信息

Mol Biol Rep. 2023 Jul;50(7):6133-6145. doi: 10.1007/s11033-023-08469-3. Epub 2023 May 22.

DOI:10.1007/s11033-023-08469-3
PMID:37217614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10202066/
Abstract

Indoleamine-2,3 dioxygenase is a rate-limiting enzyme in the tryptophan catabolism in kynurenine pathways that has an immunosuppressive effect and supports cancer cells to evade the immune system in different cancer types. Diverse cytokines and pathways upregulate the production of indoleamine-2,3 dioxygenase enzymes in the tumor microenvironment and cause more production and activity of this enzyme. Ultimately, this situation results in anti-tumor immune suppression which is in favor of tumor growth. Several inhibitors such as 1-methyl-tryptophan have been introduced for indoleamine-2,3 dioxygenase enzyme and some of them are widely utilized in pre-clinical and clinical trials. Importantly at the molecular level, indoleamine-2,3 dioxygenase is positioned in a series of intricate signaling and molecular networks. Here, the main objective is to provide a focused view of indoleamine-2,3 dioxygenase enhancer pathways and propose further studies to cover the gap in available information on the function of indoleamine-2,3 dioxygenase enzyme in the tumor microenvironment.

摘要

色氨酸-2,3 双加氧酶是犬尿氨酸途径中色氨酸分解的限速酶,具有免疫抑制作用,并支持不同类型的癌症细胞逃避免疫系统。多种细胞因子和途径上调肿瘤微环境中色氨酸-2,3 双加氧酶的产生,并导致这种酶的更多产生和活性。最终,这种情况导致抗肿瘤免疫抑制,有利于肿瘤生长。已经引入了几种色氨酸-2,3 双加氧酶抑制剂,如 1-甲基色氨酸,其中一些已广泛用于临床前和临床试验。重要的是,在分子水平上,色氨酸-2,3 双加氧酶位于一系列复杂的信号和分子网络中。在这里,主要目的是提供对色氨酸-2,3 双加氧酶增强途径的重点观察,并提出进一步的研究来填补肿瘤微环境中色氨酸-2,3 双加氧酶功能信息的空白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb67/10202066/22fa0cf48d25/11033_2023_8469_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb67/10202066/ee25a55ccb8c/11033_2023_8469_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb67/10202066/22fa0cf48d25/11033_2023_8469_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb67/10202066/ee25a55ccb8c/11033_2023_8469_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb67/10202066/22fa0cf48d25/11033_2023_8469_Fig2_HTML.jpg

相似文献

1
Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.吲哚胺-2,3 双加氧酶:肿瘤微环境的命运改变者。
Mol Biol Rep. 2023 Jul;50(7):6133-6145. doi: 10.1007/s11033-023-08469-3. Epub 2023 May 22.
2
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.吲哚胺2,3-双加氧酶-2;犬尿氨酸途径中的一种新酶。
Int J Biochem Cell Biol. 2009 Mar;41(3):467-71. doi: 10.1016/j.biocel.2008.01.005. Epub 2008 Jan 11.
3
Role of tryptophan metabolism in cancers and therapeutic implications.色氨酸代谢在癌症中的作用及其治疗意义。
Biochimie. 2021 Mar;182:131-139. doi: 10.1016/j.biochi.2021.01.005. Epub 2021 Jan 16.
4
Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.色氨酸 2,3-双加氧酶活性诱导的肿瘤生长加速及蛋白激酶相关的新型治疗方案。
Adv Exp Med Biol. 2021;1275:339-356. doi: 10.1007/978-3-030-49844-3_13.
5
Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases.吲哚胺2,3-双加氧酶:一种专业的免疫调节剂及其在免疫相关疾病中的潜在作用
Int Rev Immunol. 2022;41(3):346-363. doi: 10.1080/08830185.2020.1836176. Epub 2020 Oct 29.
6
Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.探讨色氨酸 2,3-双加氧酶在急性髓系白血病中的作用:系统评价。
Front Immunol. 2021 Mar 10;12:651687. doi: 10.3389/fimmu.2021.651687. eCollection 2021.
7
Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.色氨酸分解代谢途径前沿:吲哚胺2,3-双加氧酶(IDO)激活与调控机制综述,癌症疾病中的新靶点
Amino Acids. 2009 Jul;37(2):219-29. doi: 10.1007/s00726-008-0137-3. Epub 2008 Jul 9.
8
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.吲哚胺 2,3-双加氧酶(IDO)抑制剂与癌症免疫治疗。
Cancer Treat Rev. 2022 Nov;110:102461. doi: 10.1016/j.ctrv.2022.102461. Epub 2022 Aug 30.
9
Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.吲哚胺 2,3-双加氧酶在急性髓系白血病中的作用。
Future Oncol. 2020 Dec;16(36):3085-3094. doi: 10.2217/fon-2019-0642. Epub 2020 Sep 25.
10
Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.吲哚胺 2,3-双加氧酶 1 的新型天然化合物抑制剂的计算研究。
Aging (Albany NY). 2020 Jun 22;12(12):11349-11363. doi: 10.18632/aging.103113.

引用本文的文献

1
Probiotic intervention alters immune gene expression and tumor characteristics in experimental breast cancer.益生菌干预可改变实验性乳腺癌中的免疫基因表达和肿瘤特征。
Mol Biol Rep. 2025 Aug 8;52(1):809. doi: 10.1007/s11033-025-10873-w.
2
Advances in molecular pathology and therapy of non-small cell lung cancer.非小细胞肺癌分子病理学与治疗的进展
Signal Transduct Target Ther. 2025 Jun 15;10(1):186. doi: 10.1038/s41392-025-02243-6.
3
Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets.

本文引用的文献

1
IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells.IDO 阻断负调节乳腺癌细胞中的 CTLA-4 信号。
Immunol Res. 2023 Oct;71(5):679-686. doi: 10.1007/s12026-023-09378-0. Epub 2023 Apr 4.
2
IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.吲哚胺2,3-双加氧酶1(IDO1)可通过ADAM10下调自然杀伤细胞(NK细胞)的NKG2D配体,从而损害NK细胞对非小细胞肺癌的功能。
Pharmacol Res. 2022 Mar;177:106132. doi: 10.1016/j.phrs.2022.106132. Epub 2022 Feb 17.
3
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
胰腺癌中的免疫抑制性肿瘤微环境:机制与治疗靶点
Front Immunol. 2025 May 15;16:1582305. doi: 10.3389/fimmu.2025.1582305. eCollection 2025.
4
Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD).建立表达hsa-miR-4662a-5p的人诱导多能干细胞衍生间充质干细胞用于增强移植物抗宿主病(GVHD)中的免疫调节
Int J Mol Sci. 2025 Jan 20;26(2):847. doi: 10.3390/ijms26020847.
5
Impact of Indoleamine 2,3-Dioxygenase Enzyme Activity in Neuroendocrine Tumors.吲哚胺2,3-双加氧酶活性在神经内分泌肿瘤中的影响
Neuroendocrinology. 2025;115(5):411-421. doi: 10.1159/000543658. Epub 2025 Jan 21.
6
Advancements and challenges in stem cell transplantation for regenerative medicine.用于再生医学的干细胞移植的进展与挑战。
Heliyon. 2024 Aug 10;10(16):e35836. doi: 10.1016/j.heliyon.2024.e35836. eCollection 2024 Aug 30.
7
Non-targeted metabolomics analysis of indoleamine 2,3-dioxygenase inhibitor treatment in a mouse model of early-stage lung adenocarcinoma.吲哚胺2,3-双加氧酶抑制剂治疗早期肺腺癌小鼠模型的非靶向代谢组学分析
Transl Cancer Res. 2024 Feb 29;13(2):900-915. doi: 10.21037/tcr-23-1236. Epub 2024 Feb 26.
8
The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells.IDO 和 AHR 阻断剂的联合使用降低了乳腺癌细胞的迁移和克隆形成能力。
Immunol Res. 2024 Jun;72(3):430-437. doi: 10.1007/s12026-023-09450-9. Epub 2023 Dec 28.
9
Skin Cancer Microenvironment: What We Can Learn from Skin Aging?皮肤癌微环境:我们能从皮肤衰老中学到什么?
Int J Mol Sci. 2023 Sep 13;24(18):14043. doi: 10.3390/ijms241814043.
10
Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy.吲哚胺2,3-双加氧酶(IDO)活性:肿瘤免疫治疗实验室检测中的一种潜在生物标志物
Biomedicines. 2023 Jul 13;11(7):1988. doi: 10.3390/biomedicines11071988.
中国和美国 2022 年癌症统计数据:概况、趋势和决定因素。
Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108.
4
Toward a better understanding of T cells in cancer.向着更好地理解癌症中的 T 细胞迈进。
Cancer Cell. 2021 Dec 13;39(12):1549-1552. doi: 10.1016/j.ccell.2021.11.010.
5
Characterization of the temporal, cell-specific and interferon-inducible patterns of indoleamine 2,3 dioxygenase 1 (IDO1) expression in the human placenta across gestation.在人类妊娠过程中,对吲哚胺 2,3 双加氧酶 1(IDO1)表达的时间、细胞特异性和干扰素诱导模式进行特征描述。
Placenta. 2021 Nov;115:129-138. doi: 10.1016/j.placenta.2021.09.008. Epub 2021 Sep 14.
6
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase.对乳腺癌患者10年研究的综述:聚焦吲哚胺2,3-双加氧酶
World J Clin Oncol. 2021 Jun 24;12(6):429-436. doi: 10.5306/wjco.v12.i6.429.
7
Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services.**新冠疫情与全州范围癌症服务模式的关联**。
J Natl Cancer Inst. 2022 Jun 13;114(6):907-909. doi: 10.1093/jnci/djab122.
8
Canine mast cell tumour cells regulate tryptophan catabolism via the expression of indoleamine 2,3-dioxygenase.犬肥大细胞瘤细胞通过表达吲哚胺 2,3-双加氧酶调节色氨酸分解代谢。
Res Vet Sci. 2021 Jul;137:159-162. doi: 10.1016/j.rvsc.2021.04.030. Epub 2021 Apr 30.
9
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy.临床试验中用于癌症免疫治疗的吲哚胺 2,3-双加氧酶 1(IDO1)抑制剂。
J Hematol Oncol. 2021 Apr 21;14(1):68. doi: 10.1186/s13045-021-01080-8.
10
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.单细胞分析鉴定出浸润在神经胶质瘤中的 T 细胞中的抑制性 CD161 受体。
Cell. 2021 Mar 4;184(5):1281-1298.e26. doi: 10.1016/j.cell.2021.01.022. Epub 2021 Feb 15.